VIV Podcast

Combination Products: Successful Product Development & Regulatory Anticipations & Complexities

Combination products are everywhere. As increasingly more enter the market we are continuously questioning the unique strategies necessary for development of a product across multi-disciplinary teams. Staying up to date with changing patient needs, monitoring emerging global regulatory requirements and efficiently delivering high-quality products is only a small part of it – and now you need to do this, and more, times two! Today we have invited an expert panel of industry professionals to join us in this discussion as we highlight key concepts for drug/device combination products, best practices for adoption of 21 CFR Part 4, supply disruptions, and, of course, global regulatory variances.

Listen in to our highly esteemed panel of experts: Becky Leibowitz from Janssen, Kurt Moyer from Pine Lake Laboratories, and Alan Golden from Design Quality Consultants.  Facilitating that discussion will be our moderator, Roberta Goode.

Resources for THIS Episode:


Product Added Successfully

This product has been added to your account and you can access it from your dashboard. As a member, you are entitled to a total of 0 products.

Do you want access to more of our products? Upgrade your membership now!

Your Product count is over the limit

Do you want access to more of our products? Upgrade your membership now!

Product added to cart successfully.

You can continue shopping or proceed to checkout.

Comments (0)

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
  • Use to create page breaks.
Enter the characters shown in the image.
Validated Cloud logo